Market Overview

I think you’ll love what you hear,
what you’ll see and the opportunities
that will be set before you.
- Jon Najarian

For Medtronic, J.P. Morgan Expects Another Round Of Downward Guidance


Medtronic Inc. (NYSE: MDT) is scheduled to report 2Q results on Tuesday, November 23, J.P. Morgan reports.

“Our forecast calls for revenues of $3.885B (+1.2% reported, 2.2% constant currency, and 1.0% organic) and EPS of $0.81 (+6.2%),” J.P. Morgan writes.

“While this is a tad better than the company's 1Q performance, it is still at the lower end of consensus and in all likelihood sets the stage for another round of downward guidance revisions for the company's FY 2011.”

Medtronic currently trades at $35.49.

Posted-In: J.P. Morgan MedtronicAnalyst Ratings


Related Articles (MDT)

View Comments and Join the Discussion!

Latest Ratings

View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Five Ways the Cell Phone Is Changing the World

Softs Market Commentary